For example, overexpression of MEX3B in tumors can reduce the lethality of tumor-infiltrating lymphocytes, thereby mediating tumor immunotherapy resistance (Huang et al., 2018); NONO promotes cancer proliferation by regulating SKP2 and E2F8, significantly affecting patient prognosis (Iino et al., 2020). This evidence concerns the gene MEX3B and neoplasm.